A study in the New England Journal of Medicine found that treatment with a leukotriene-receptor antagonist (LTRA) was as effective as inhaled glucocorticoid therapy as first-line controller therapy in asthma. Read more http://www.nejm.org/doi/full/10.1056/NEJMoa1010846?query=featured_home.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder